Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Biogen Inc. (NASDAQ: BIIB)
BIIB Stock Predictions and Ratings
WSX Rating:
HOLD
WSX Forecast (1yr):
3.80%
Analyst Rating:
BUY
Analyst Forecast (1yr):
13.30%
BIIB Stock Analysis
BIIB
PE Ratio:
21.1
BIIB
PEG Ratio:
Not Available
BIIB
Forward EPS Growth (12 month):
0.00%
BIIB
PS Ratio:
2.9
BIIB
PSG Ratio:
Not Available
BIIB
Forward Revenue Growth (12 month):
0.00%
BIIB Articles
No data was found